drug hepatotoxicity
Cochrane systematic review
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy
Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
Temporal trends in new and recurrent oesophageal strictures in a Medicare population
Oral budesonide in the treatment of chronic refractory pouchitis
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease
Publication of a negative trial without disclosing the drug
Publication of a negative trial without disclosing the drug
Corrigendum